This inventor holds 1 USPTO granted patent. Top assignee: Medizinische Hochschule Hannover. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Florian Kuehnel: Innovator in Anti-Tumor Medicament Development
Introduction
Florian Kuehnel is a notable inventor based in Hanover, Germany. He has made significant contributions to the field of medicine, particularly in the development of innovative treatments for tumors. His work focuses on utilizing manipulated adenoviruses as a therapeutic approach.
Latest Patents
Florian Kuehnel holds a patent for an anti-tumor medicament based on adenovirus. This invention provides a viral particle that is specifically designed for use as a medicament in the treatment of tumors. The unique aspect of this viral particle is its preference for tumor cells, which allows for a more effective infection of these cells. The adenovirus used in this invention is primarily type C, with a focus on serotype 2 (Ad2) and serotype 5 (Ad5). The native fiber protein of the virus has been deleted and replaced with a fusion protein that targets cell surface-bound polysialic acid.
Career Highlights
Florian Kuehnel is affiliated with the Medical University of Hanover, where he conducts his research and development work. His innovative approach to cancer treatment has positioned him as a key figure in the medical research community.
Collaborations
Florian collaborates with esteemed colleagues, including Nikolas Martin and David Schwarzer. Their combined expertise enhances the research and development efforts in the field of tumor treatment.
Conclusion
Florian Kuehnel's contributions to the development of anti-tumor medicaments highlight the potential of manipulated adenoviruses in cancer therapy. His innovative work continues to pave the way for advancements in medical treatments.